aap Reports 1Q19 Revenue of €3.5MM, +23.4% vs. 1Q18

by Mike Evers on May 15, 2019

aap Implantate reported 1Q19 revenue of €3.5MM (USD $3.9MM), +23.4% vs. 1Q18.

Sustained momentum from 4Q in Germany with +15% growth, and rebounded in North America with +22% growth
Improved margin by focusing on high-margin markets and improved product mix
Continued to make progress on clinical approvals for LOQTEQ...

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

	1Q19	1Q18	$ Chg	% Chg
Trauma	$3.9	$3.1	$0.7	23.4%

Geographic Region	1Q19	1Q18	$ Chg	% Chg
US	$0.7	$0.5	$0.1	21.7%
Ex-US	$3.2	$2.6	$0.6	23.7%
Total	$3.9	$3.1	$0.7	23.4%

	1Q19	1Q18	$ Chg	% Chg
Trauma	$3.9	$3.1	$0.7	23.4%

Geographic Region	1Q19	1Q18	$ Chg	% Chg
US	$0.7	$0.5	$0.1	21.7%
Ex-US	$3.2	$2.6	$0.6	23.7%
Total	$3.9	$3.1	$0.7	23.4%

aap Reports 1Q19 Revenue of €3.5MM, +23.4% vs. 1Q18

VB Spine Partners on Predictive Blood Test for Scoliosis

Stryker Gaining Ground in OUS Hip Replacement Market

Materialise Invests in Replasia to Support Hip Preservation Innovation

Volatile International Markets Bring Challenges in Early 2026

Garland Surgical Closes €3.5M Seed Round

Get the ORTHOWORLD Newsletter!

Contact Us